Global Sepsis and Septic Shock Treatment Market Research Report 2023

Sepsis and Septic Shock Treatment Market

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sepsis and Septic Shock Treatment market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sepsis and Septic Shock Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Sepsis and Septic Shock Treatment Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sepsis and Septic Shock Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Cephalosporin

1.2.3 Pencillin

1.2.4 Macrolides

1.2.5 Others

1.3 Market by Application

1.3.1 Global Sepsis and Septic Shock Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Sepsis

1.3.3 Septic Shock

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Sepsis and Septic Shock Treatment Market Perspective (2018-2029)

2.2 Sepsis and Septic Shock Treatment Growth Trends by Region

2.2.1 Global Sepsis and Septic Shock Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Sepsis and Septic Shock Treatment Historic Market Size by Region (2018-2023)

2.2.3 Sepsis and Septic Shock Treatment Forecasted Market Size by Region (2024-2029)

2.3 Sepsis and Septic Shock Treatment Market Dynamics

2.3.1 Sepsis and Septic Shock Treatment Industry Trends

2.3.2 Sepsis and Septic Shock Treatment Market Drivers

2.3.3 Sepsis and Septic Shock Treatment Market Challenges

2.3.4 Sepsis and Septic Shock Treatment Market Restraints

3.1 Global Top Sepsis and Septic Shock Treatment Players by Revenue

3.1.1 Global Top Sepsis and Septic Shock Treatment Players by Revenue (2018-2023)

3.1.2 Global Sepsis and Septic Shock Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Sepsis and Septic Shock Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Sepsis and Septic Shock Treatment Revenue

3.4 Global Sepsis and Septic Shock Treatment Market Concentration Ratio

3.4.1 Global Sepsis and Septic Shock Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sepsis and Septic Shock Treatment Revenue in 2022

3.5 Sepsis and Septic Shock Treatment Key Players Head office and Area Served

3.6 Key Players Sepsis and Septic Shock Treatment Product Solution and Service

3.7 Date of Enter into Sepsis and Septic Shock Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Sepsis and Septic Shock Treatment Historic Market Size by Type (2018-2023)

4.2 Global Sepsis and Septic Shock Treatment Forecasted Market Size by Type (2024-2029)

5.1 Global Sepsis and Septic Shock Treatment Historic Market Size by Application (2018-2023)

5.2 Global Sepsis and Septic Shock Treatment Forecasted Market Size by Application (2024-2029)

6.1 North America Sepsis and Septic Shock Treatment Market Size (2018-2029)

6.2 North America Sepsis and Septic Shock Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Sepsis and Septic Shock Treatment Market Size by Country (2018-2023)

6.4 North America Sepsis and Septic Shock Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Sepsis and Septic Shock Treatment Market Size (2018-2029)

7.2 Europe Sepsis and Septic Shock Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Sepsis and Septic Shock Treatment Market Size by Country (2018-2023)

7.4 Europe Sepsis and Septic Shock Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Sepsis and Septic Shock Treatment Market Size (2018-2029)

8.2 Asia-Pacific Sepsis and Septic Shock Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Sepsis and Septic Shock Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Sepsis and Septic Shock Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Sepsis and Septic Shock Treatment Market Size (2018-2029)

9.2 Latin America Sepsis and Septic Shock Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Sepsis and Septic Shock Treatment Market Size by Country (2018-2023)

9.4 Latin America Sepsis and Septic Shock Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Sepsis and Septic Shock Treatment Market Size (2018-2029)

10.2 Middle East & Africa Sepsis and Septic Shock Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Sepsis and Septic Shock Treatment Introduction

11.1.4 Pfizer Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 NCPC

11.2.1 NCPC Company Detail

11.2.2 NCPC Business Overview

11.2.3 NCPC Sepsis and Septic Shock Treatment Introduction

11.2.4 NCPC Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.2.5 NCPC Recent Development

11.3 Bayer

11.3.1 Bayer Company Detail

11.3.2 Bayer Business Overview

11.3.3 Bayer Sepsis and Septic Shock Treatment Introduction

11.3.4 Bayer Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.3.5 Bayer Recent Development

11.4 Shanghai Pharmaceuticals

11.4.1 Shanghai Pharmaceuticals Company Detail

11.4.2 Shanghai Pharmaceuticals Business Overview

11.4.3 Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Introduction

11.4.4 Shanghai Pharmaceuticals Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.4.5 Shanghai Pharmaceuticals Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Detail

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Sepsis and Septic Shock Treatment Introduction

11.5.4 Johnson & Johnson Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.5.5 Johnson & Johnson Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis Sepsis and Septic Shock Treatment Introduction

11.6.4 Novartis Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.6.5 Novartis Recent Development

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Detail

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Sepsis and Septic Shock Treatment Introduction

11.7.4 GlaxoSmithKline Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.7.5 GlaxoSmithKline Recent Development

11.8 TEVA

11.8.1 TEVA Company Detail

11.8.2 TEVA Business Overview

11.8.3 TEVA Sepsis and Septic Shock Treatment Introduction

11.8.4 TEVA Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.8.5 TEVA Recent Development

11.9 Viatris

11.9.1 Viatris Company Detail

11.9.2 Viatris Business Overview

11.9.3 Viatris Sepsis and Septic Shock Treatment Introduction

11.9.4 Viatris Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.9.5 Viatris Recent Development

11.10 AbbVie

11.10.1 AbbVie Company Detail

11.10.2 AbbVie Business Overview

11.10.3 AbbVie Sepsis and Septic Shock Treatment Introduction

11.10.4 AbbVie Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.10.5 AbbVie Recent Development

11.11 Merck & Co

11.11.1 Merck & Co Company Detail

11.11.2 Merck & Co Business Overview

11.11.3 Merck & Co Sepsis and Septic Shock Treatment Introduction

11.11.4 Merck & Co Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.11.5 Merck & Co Recent Development

11.12 Asahi Kasei

11.12.1 Asahi Kasei Company Detail

11.12.2 Asahi Kasei Business Overview

11.12.3 Asahi Kasei Sepsis and Septic Shock Treatment Introduction

11.12.4 Asahi Kasei Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.12.5 Asahi Kasei Recent Development

11.13 AtoxBio

11.13.1 AtoxBio Company Detail

11.13.2 AtoxBio Business Overview

11.13.3 AtoxBio Sepsis and Septic Shock Treatment Introduction

11.13.4 AtoxBio Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.13.5 AtoxBio Recent Development

11.14 INOTREM

11.14.1 INOTREM Company Detail

11.14.2 INOTREM Business Overview

11.14.3 INOTREM Sepsis and Septic Shock Treatment Introduction

11.14.4 INOTREM Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.14.5 INOTREM Recent Development

11.15 Adrenomed

11.15.1 Adrenomed Company Detail

11.15.2 Adrenomed Business Overview

11.15.3 Adrenomed Sepsis and Septic Shock Treatment Introduction

11.15.4 Adrenomed Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.15.5 Adrenomed Recent Development

11.16 Endacea

11.16.1 Endacea Company Detail

11.16.2 Endacea Business Overview

11.16.3 Endacea Sepsis and Septic Shock Treatment Introduction

11.16.4 Endacea Revenue in Sepsis and Septic Shock Treatment Business (2018-2023)

11.16.5 Endacea Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Sepsis and Septic Shock Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Cephalosporin

    Table 3. Key Players of Pencillin

    Table 4. Key Players of Macrolides

    Table 5. Key Players of Others

    Table 6. Global Sepsis and Septic Shock Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Sepsis and Septic Shock Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Sepsis and Septic Shock Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Sepsis and Septic Shock Treatment Market Share by Region (2018-2023)

    Table 10. Global Sepsis and Septic Shock Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Sepsis and Septic Shock Treatment Market Share by Region (2024-2029)

    Table 12. Sepsis and Septic Shock Treatment Market Trends

    Table 13. Sepsis and Septic Shock Treatment Market Drivers

    Table 14. Sepsis and Septic Shock Treatment Market Challenges

    Table 15. Sepsis and Septic Shock Treatment Market Restraints

    Table 16. Global Sepsis and Septic Shock Treatment Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Sepsis and Septic Shock Treatment Market Share by Players (2018-2023)

    Table 18. Global Top Sepsis and Septic Shock Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis and Septic Shock Treatment as of 2022)

    Table 19. Ranking of Global Top Sepsis and Septic Shock Treatment Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Sepsis and Septic Shock Treatment Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Sepsis and Septic Shock Treatment Product Solution and Service

    Table 23. Date of Enter into Sepsis and Septic Shock Treatment Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Sepsis and Septic Shock Treatment Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Sepsis and Septic Shock Treatment Revenue Market Share by Type (2018-2023)

    Table 27. Global Sepsis and Septic Shock Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Sepsis and Septic Shock Treatment Revenue Market Share by Type (2024-2029)

    Table 29. Global Sepsis and Septic Shock Treatment Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Sepsis and Septic Shock Treatment Revenue Market Share by Application (2018-2023)

    Table 31. Global Sepsis and Septic Shock Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Sepsis and Septic Shock Treatment Revenue Market Share by Application (2024-2029)

    Table 33. North America Sepsis and Septic Shock Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Sepsis and Septic Shock Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Sepsis and Septic Shock Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Sepsis and Septic Shock Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Sepsis and Septic Shock Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Sepsis and Septic Shock Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Sepsis and Septic Shock Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Sepsis and Septic Shock Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Sepsis and Septic Shock Treatment Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Sepsis and Septic Shock Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Sepsis and Septic Shock Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Sepsis and Septic Shock Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Sepsis and Septic Shock Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Pfizer Company Detail

    Table 49. Pfizer Business Overview

    Table 50. Pfizer Sepsis and Septic Shock Treatment Product

    Table 51. Pfizer Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 52. Pfizer Recent Development

    Table 53. NCPC Company Detail

    Table 54. NCPC Business Overview

    Table 55. NCPC Sepsis and Septic Shock Treatment Product

    Table 56. NCPC Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 57. NCPC Recent Development

    Table 58. Bayer Company Detail

    Table 59. Bayer Business Overview

    Table 60. Bayer Sepsis and Septic Shock Treatment Product

    Table 61. Bayer Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 62. Bayer Recent Development

    Table 63. Shanghai Pharmaceuticals Company Detail

    Table 64. Shanghai Pharmaceuticals Business Overview

    Table 65. Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Product

    Table 66. Shanghai Pharmaceuticals Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 67. Shanghai Pharmaceuticals Recent Development

    Table 68. Johnson & Johnson Company Detail

    Table 69. Johnson & Johnson Business Overview

    Table 70. Johnson & Johnson Sepsis and Septic Shock Treatment Product

    Table 71. Johnson & Johnson Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 72. Johnson & Johnson Recent Development

    Table 73. Novartis Company Detail

    Table 74. Novartis Business Overview

    Table 75. Novartis Sepsis and Septic Shock Treatment Product

    Table 76. Novartis Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 77. Novartis Recent Development

    Table 78. GlaxoSmithKline Company Detail

    Table 79. GlaxoSmithKline Business Overview

    Table 80. GlaxoSmithKline Sepsis and Septic Shock Treatment Product

    Table 81. GlaxoSmithKline Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 82. GlaxoSmithKline Recent Development

    Table 83. TEVA Company Detail

    Table 84. TEVA Business Overview

    Table 85. TEVA Sepsis and Septic Shock Treatment Product

    Table 86. TEVA Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 87. TEVA Recent Development

    Table 88. Viatris Company Detail

    Table 89. Viatris Business Overview

    Table 90. Viatris Sepsis and Septic Shock Treatment Product

    Table 91. Viatris Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 92. Viatris Recent Development

    Table 93. AbbVie Company Detail

    Table 94. AbbVie Business Overview

    Table 95. AbbVie Sepsis and Septic Shock Treatment Product

    Table 96. AbbVie Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 97. AbbVie Recent Development

    Table 98. Merck & Co Company Detail

    Table 99. Merck & Co Business Overview

    Table 100. Merck & Co Sepsis and Septic Shock Treatment Product

    Table 101. Merck & Co Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 102. Merck & Co Recent Development

    Table 103. Asahi Kasei Company Detail

    Table 104. Asahi Kasei Business Overview

    Table 105. Asahi Kasei Sepsis and Septic Shock Treatment Product

    Table 106. Asahi Kasei Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 107. Asahi Kasei Recent Development

    Table 108. AtoxBio Company Detail

    Table 109. AtoxBio Business Overview

    Table 110. AtoxBio Sepsis and Septic Shock Treatment Product

    Table 111. AtoxBio Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 112. AtoxBio Recent Development

    Table 113. INOTREM Company Detail

    Table 114. INOTREM Business Overview

    Table 115. INOTREM Sepsis and Septic Shock Treatment Product

    Table 116. INOTREM Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 117. INOTREM Recent Development

    Table 118. Adrenomed Company Detail

    Table 119. Adrenomed Business Overview

    Table 120. Adrenomed Sepsis and Septic Shock Treatment Product

    Table 121. Adrenomed Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 122. Adrenomed Recent Development

    Table 123. Endacea Company Detail

    Table 124. Endacea Business Overview

    Table 125. Endacea Sepsis and Septic Shock Treatment Product

    Table 126. Endacea Revenue in Sepsis and Septic Shock Treatment Business (2018-2023) & (US$ Million)

    Table 127. Endacea Recent Development

    Table 128. Research Programs/Design for This Report

    Table 129. Key Data Information from Secondary Sources

    Table 130. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Sepsis and Septic Shock Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Sepsis and Septic Shock Treatment Market Share by Type: 2022 VS 2029

    Figure 3. Cephalosporin Features

    Figure 4. Pencillin Features

    Figure 5. Macrolides Features

    Figure 6. Others Features

    Figure 7. Global Sepsis and Septic Shock Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Sepsis and Septic Shock Treatment Market Share by Application: 2022 VS 2029

    Figure 9. Sepsis Case Studies

    Figure 10. Septic Shock Case Studies

    Figure 11. Sepsis and Septic Shock Treatment Report Years Considered

    Figure 12. Global Sepsis and Septic Shock Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Sepsis and Septic Shock Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Sepsis and Septic Shock Treatment Market Share by Region: 2022 VS 2029

    Figure 15. Global Sepsis and Septic Shock Treatment Market Share by Players in 2022

    Figure 16. Global Top Sepsis and Septic Shock Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis and Septic Shock Treatment as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Sepsis and Septic Shock Treatment Revenue in 2022

    Figure 18. North America Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Sepsis and Septic Shock Treatment Market Share by Country (2018-2029)

    Figure 20. United States Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Sepsis and Septic Shock Treatment Market Share by Country (2018-2029)

    Figure 24. Germany Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Sepsis and Septic Shock Treatment Market Share by Region (2018-2029)

    Figure 32. China Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Sepsis and Septic Shock Treatment Market Share by Country (2018-2029)

    Figure 40. Mexico Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Sepsis and Septic Shock Treatment Market Share by Country (2018-2029)

    Figure 44. Turkey Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Sepsis and Septic Shock Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Pfizer Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 47. NCPC Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 48. Bayer Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 49. Shanghai Pharmaceuticals Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 50. Johnson & Johnson Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 51. Novartis Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 52. GlaxoSmithKline Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 53. TEVA Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 54. Viatris Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 55. AbbVie Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 56. Merck & Co Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 57. Asahi Kasei Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 58. AtoxBio Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 59. INOTREM Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 60. Adrenomed Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 61. Endacea Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2018-2023)

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed